Sartorius Stedim Biotech Share Price

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 09:25:00 11/07/2025 pm IST 5-day change 1st Jan Change
203.70 EUR -0.97% Intraday chart for Sartorius Stedim Biotech -0.10% +7.95%

Valuation: Sartorius Stedim Biotech

Capitalization 1.98TCr 2.32TCr 1.85TCr 1.72TCr 3.17TCr 1,98900Cr 3.53TCr 22TCr 8.46TCr 93TCr 8.69TCr 8.51TCr 3,41600Cr P/E ratio 2025 *
57.8x
P/E ratio 2026 * 45.1x
Enterprise value 2.19TCr 2.56TCr 2.04TCr 1.9TCr 3.51TCr 2,19800Cr 3.9TCr 24TCr 9.35TCr 1,02900Cr 9.61TCr 9.41TCr 3,77500Cr EV / Sales 2025 *
7.36x
EV / Sales 2026 * 6.59x
Free-Float
30.28%
Yield 2025 *
0.38%
Yield 2026 * 0.47%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.97%
1 week-0.10%
Current month+0.44%
1 month+0.74%
3 months+25.24%
6 months+1.55%
Current year+7.95%
More quotes
1 week 195.25
Extreme 195.25
206.3
1 month 193
Extreme 193
208.5
Current year 148.75
Extreme 148.75
239.8
1 year 143.2
Extreme 143.2
239.8
3 years 139.1
Extreme 139.1
400
5 years 139.1
Extreme 139.1
551
10 years 39.85
Extreme 39.85
551
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 28/03/2023
Chief Tech/Sci/R&D Officer 60 08/09/2011
Investor Relations Contact 56 -
Director TitleAgeSince
Director/Board Member 64 07/04/2015
Director/Board Member 68 07/04/2015
Director/Board Member 68 14/09/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.97%-0.10%+20.93%-40.66% 2.32TCr
-1.18%-1.80%+26.72%+21.24% 23TCr
+0.58%+1.73%+15.18%+1.09% 12TCr
-0.71%-0.34%+32.98%+108.89% 5.72TCr
-0.86%-0.11%-21.77%-27.79% 5.04TCr
+0.34%+7.24%-14.11%+40.53% 4.15TCr
-2.45%+0.53%-26.00%+6.30% 3.27TCr
+0.49%-0.83%-11.48%+15.57% 2.46TCr
-1.17%-4.01%+4.68%+9.06% 2.24TCr
-2.72%-3.90%+42.09%+25.34% 2.04TCr
Average -0.69%+0.05%+6.92%+15.96% 6.17TCr
Weighted average by Cap. -0.06%+0.18%+13.61%+19.25%
See all sector performances

Financials

2025 *2026 *
Net sales 297.69Cr 348.13Cr 277.28Cr 257.9Cr 476.53Cr 30TCr 529.57Cr 3.32TCr 1.27TCr 14TCr 1.31TCr 1.28TCr 51TCr 329.6Cr 385.45Cr 307.01Cr 285.55Cr 527.62Cr 33TCr 586.35Cr 3.68TCr 1.41TCr 15TCr 1.45TCr 1.42TCr 57TCr
Net income 34Cr 40Cr 32Cr 30Cr 55Cr 3.42TCr 61Cr 380.57Cr 145.51Cr 1.6TCr 149.55Cr 146.47Cr 5.88TCr 44Cr 51Cr 41Cr 38Cr 70Cr 4.4TCr 78Cr 489.16Cr 187.02Cr 2.06TCr 192.23Cr 188.26Cr 7.55TCr
Net Debt 208.72Cr 244.09Cr 194.41Cr 180.82Cr 334.11Cr 21TCr 371.3Cr 2.33TCr 890.67Cr 9.81TCr 915.44Cr 896.57Cr 36TCr 189.67Cr 221.81Cr 176.67Cr 164.32Cr 303.62Cr 19TCr 337.42Cr 2.12TCr 809.39Cr 8.91TCr 831.9Cr 814.75Cr 33TCr
More financial data * Estimated data
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
9,961
More about the company
Date Price Change Volume
11/25/11 203.70 -0.97% 31,902
10/25/10 205.70 +2.64% 34,861
09/25/09 200.40 -0.50% 32,701
08/25/08 201.40 +0.60% 55,366
07/25/07 200.20 -1.81% 31,885

Real-time Euronext Paris, July 11, 2025 at 09:25 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
203.70EUR
Average target price
241.69EUR
Spread / Average Target
+18.65%
Consensus

Quarterly revenue - Rate of surprise